Channelpedia

PubMed 19494570


Referenced in Channelpedia wiki pages of: none

Automatically associated channels: KCNQ4 , Kv7.4



Title: Therapeutic regulation of gene expression in the inner ear using RNA interference.

Authors: Yukihide Maeda, Abraham M Sheffield, Richard J H Smith

Journal, date & volume: Adv. Otorhinolaryngol., 2009 , 66, 13-36

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/19494570


Abstract
Targeting and downregulating specific genes with antisense and decoy oligonucleotides, ribozymes or RNA interference (RNAi) offer the theoretical potential of altering a disease phenotype. Here we review the molecular mechanism behind the in vivo application of RNAi-mediated gene silencing, focusing on its application to the inner ear. RNAi is a physiological phenomenon in which small, double-stranded RNA molecules (small interfering RNA, siRNA) reduce expression of homologous genes. Notable for its exquisite sequence specificity, it is ideally applied to diseases caused by a gain-of-function mechanism of action. Types of deafness in which gain-of-function mutations are observed include DFNA2 (KCNQ4), DFNA3 (GJB2) and DFNA5 (DFNA5). Several strategies can be used to deliver siRNA into the inner ear, including cationic liposomes, adeno-associated and lentiviral vectors, and adenoviral vectors. Transduction efficiency with cationic liposomes is low and the effect is transient; with adeno-associated and lentiviral vectors, long-term transfection is possible using a small hairpin RNA expression cassette.